Marketing and publicity strategies for launching the pilot phase of the Hong Kong Genome Project

Abstract

Aim: Public trust and confidence determine the acceptance of any population-based genome project. The Hong Kong Genome Institute (HKGI) was established in May 2020 by the Food and Health Bureau (Currently the Health Bureau) to spearhead the integration of genomic medicine into mainstream healthcare. One of HKGI’s goals is to enhance public genomic literacy and engagement by launching the Hong Kong Genome Project (HKGP).

Methods: Three focus groups (undiagnosed and rare disease patients and their families, hereditary cancer patients and their families, and clinical geneticists and other medical subspecialists) involving 20 patients, family members, and healthcare professionals were completed in mid-2021 by an independent party. The aim was to harness insights into stakeholders’ views, concerns, and aspirations on issues related to genomic studies and the HKGP: (1) the decision to undergo genetic testing; (2) concerns; (3) campaign format; and (4) other strategic suggestions for the Pilot Phase. These issues are complex and multifactorial and have not been documented in Chinese populations. The qualitative approach facilitates such exploration.

Results: Four themes emerged from the thematic analysis: (1) decisional considerations of undertaking genetic testing: perceived benefits and motivators; (2) concerns and worries: personal, familial, and societal concerns; (3) a quest for a patient-oriented, transparent, and decommercialized whole-genome sequencing campaign; and (4) communicating genomics efficaciously: the importance of informational support and literacy enhancement.

Conclusion: Our results shaped the strategies for publicizing the Pilot Phase of HKGP and laid a patient-oriented foundation for HKGP’s Main Phase.

Keywords

Hong Kong Genome Project / genomic medicine / whole-genome sequencing / public awareness / genomic literacy

References

[1] MiddletonA,ThorogoodA.Attitudes of publics who are unwilling to donate DNA data for research.Eur J Med Genet2019;62:316-23 PMCID:PMC6582635

[2] DheensaS,FenwickA.Fostering trust in healthcare: participants’ experiences, views, and concerns about the 100,000 genomes project.Eur J Med Genet2019;62:335-41

[3] MiddletonA,AlmarriMA.Global public perceptions of genomic data sharing: what shapes the willingness to donate DNA and health data?.Am J Hum Genet2020;107:743-52 PMCID:PMC7536612

[4] MiddletonA,BorraJ.A public backlash towards genomics is a risk all of us working in genomics must share.Lancet Reg Health Eur2022;15:100347 PMCID:PMC8927847

[5] ChuATW,TongAHY.Potentials and challenges of launching the pilot phase of Hong Kong Genome Project.J Transl Genet Genom2022;6:290-303

[6] Hong Kong Genome Institute. Strategic Plan 2022-25. 2022. Available from: https://hkgp.org/wp-content/uploads/2022/07/HKGI-Strategic-Plan-2022-25.pdf [Last accessed on 22 March 2023]

[7] ClarkeV,HayfieldN. Thematic analysis. In: Smith J, editor. Qualitative psychology: a practical guide to research methods. London: Sage Publications Ltd; 2015. pp. 222-48. Available from: https://www.torrossa.com/en/resources/an/5018480#page=233 [Last accessed on 20 Mar 2023]

[8] NowellLS,WhiteDE.Thematic analysis: striving to meet the trustworthiness criteria.Int J Qual Meth2017;16:160940691773384

[9] LewisC,HillM.Parents’ motivations, concerns and understanding of genome sequencing: a qualitative interview study.Eur J Hum Genet2020;28:874-84 PMCID:PMC7316711

[10] MackleyMP,ParkerM,WatkinsH.Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study.Eur J Hum Genet2018;26:652-9 PMCID:PMC5945590

[11] BerriosC,RaraighK.Enrolling genomics research participants through a clinical setting: the impact of existing clinical relationships on informed consent and expectations for return of research results.J Genet Couns2018;27:263-73 PMCID:PMC7539290

[12] AndersonJA,ShumanC.Parents perspectives on whole genome sequencing for their children: qualified enthusiasm?.J Med Ethics2017;43:535-9

[13] ChungCCY,ChungBHY.Rare disease emerging as a global public health priority.Front Public Health2022;10:1028545 PMCID:PMC9632971

[14] SandersonSC,HillM.Decision-making, attitudes, and understanding among patients and relatives invited to undergo genome sequencing in the 100,000 Genomes Project: a multisite survey study.Genet Med2022;24:61-74

[15] StilesD.Cases in precision medicine: concerns about privacy and discrimination after genomic sequencing.Ann Intern Med2019;170:717-21 PMCID:PMC6715527

[16] AmendolaLM,HartR.Why patients decline genomic sequencing studies: experiences from the CSER consortium.J Genet Couns2018;27:1220-7 PMCID:PMC6119550

[17] HoffmanSJ,NattN.Celebrities’ impact on health-related knowledge, attitudes, behaviors, and status outcomes: protocol for a systematic review, meta-analysis, and meta-regression analysis.Syst Rev2017;6:13 PMCID:PMC5251292

[18] WangW. Twenty-First century celebrity: fame in digital culture. 2018, 256p. Available from: https://www.emerald.com/insight/publication/doi/10.1108/9781787437081 [Last accessed on 20 Mar 2023]

[19] Hong Kong Genome Institute. Available from: https://hkgp.org/en/ [Last accessed on 20 Mar 2023]

[20] CheungNYC,NgYNC.Perception of personalized medicine, pharmacogenomics, and genetic testing among undergraduates in Hong Kong.Hum Genomics2021;15:54 PMCID:PMC8371796

[21] ZimaniAN,KovandaA.Increasing genomic literacy through national genomic projects.Front Genet2021;12:693253 PMCID:PMC8387713

[22] Department of Health & Social Care. Genome UK: 2021 to 2022 implementation plan 2021. [Available from: https://www.gov.uk/government/publications/genome-uk-2021-to-2022-implementation-plan/genome-uk-2021-to-2022-implementation-plan [Last accessed on 20 Mar 2023]

[23] Qatar Genome Program. Available from: https://www.qatargenome.org.qa/about-qgp/qatar-genome/journey [Last accessed on 20 Mar 2023]